122 related articles for article (PubMed ID: 9712052)
1. The invariant chain gene intronic enhancer shows homology to class II promoter elements.
Moore BB; Cao ZA; McRae TL; Woo CH; Conley S; Jones PP
J Immunol; 1998 Aug; 161(4):1844-52. PubMed ID: 9712052
[TBL] [Abstract][Full Text] [Related]
2. Identification of an IFN-gamma responsive region in an intron of the invariant chain gene.
Cao ZA; Moore BB; Quezada D; Chang CH; Jones PP
Eur J Immunol; 2000 Sep; 30(9):2604-11. PubMed ID: 11009094
[TBL] [Abstract][Full Text] [Related]
3. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II-associated invariant chain gene.
Brown AM; Barr CL; Ting JP
J Immunol; 1991 May; 146(9):3183-9. PubMed ID: 1901895
[TBL] [Abstract][Full Text] [Related]
4. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.
Zhu L; Jones PP
Mol Cell Biol; 1990 Aug; 10(8):3906-16. PubMed ID: 2115116
[TBL] [Abstract][Full Text] [Related]
6. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
Powis SJ
FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
[TBL] [Abstract][Full Text] [Related]
7. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC.
Liang MN; Lee C; Xia Y; McConnell HM
Biochemistry; 1996 Nov; 35(47):14734-42. PubMed ID: 8942634
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
11. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
Harnesk K; Swanberg M; Diez M; Olsson T; Piehl F; Lidman O
J Neuroimmunol; 2009 Jul; 212(1-2):44-52. PubMed ID: 19481818
[TBL] [Abstract][Full Text] [Related]
12. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
[TBL] [Abstract][Full Text] [Related]
13. Identification of bovine invariant chain (Ii) gene by nucleotide sequencing.
Niimi M; Nakai Y; Aida Y
Biochem Biophys Res Commun; 1996 May; 222(1):7-12. PubMed ID: 8630076
[TBL] [Abstract][Full Text] [Related]
14. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
15. The E alpha promoter: a linker-scanning analysis.
Viville S; Jongeneel V; Koch W; Mantovani R; Benoist C; Mathis D
J Immunol; 1991 May; 146(9):3211-7. PubMed ID: 1901896
[TBL] [Abstract][Full Text] [Related]
16. pRB is required for interferon-gamma-induction of the MHC class II abeta gene.
Zhu X; Pattenden S; Bremner R
Oncogene; 1999 Sep; 18(35):4940-7. PubMed ID: 10490828
[TBL] [Abstract][Full Text] [Related]
17. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.
Dixon AM; Stanley BJ; Matthews EE; Dawson JP; Engelman DM
Biochemistry; 2006 Apr; 45(16):5228-34. PubMed ID: 16618111
[TBL] [Abstract][Full Text] [Related]
18. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
19. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
20. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
